These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21560107)

  • 1. [Positron emission tomography in tumors of the upper gastrointestinal tract: controversial value].
    Vallböhmer D; Hölscher AH
    Dtsch Med Wochenschr; 2011 May; 136(20):1060. PubMed ID: 21560107
    [No Abstract]   [Full Text] [Related]  

  • 2. [Positron emission tomography - current role in the diagnosis and treatment of upper gastrointestinal carcinomas].
    Lordick F; Ott K; Krause BJ
    Dtsch Med Wochenschr; 2011 May; 136(20):1061-6. PubMed ID: 21560108
    [No Abstract]   [Full Text] [Related]  

  • 3. Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
    Suzuki H; Hasegawa Y; Terada A; Ogawa T; Hyodo I; Suzuki M; Nakashima T; Tamaki T; Nishio M
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1191-5. PubMed ID: 19015450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography in gastric and esophageal cancer.
    Flamen P
    Curr Opin Oncol; 2004 Jul; 16(4):359-63. PubMed ID: 15187891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography.
    Roedl JB; Harisinghani MG; Colen RR; Fischman AJ; Blake MA; Mathisen DJ; Mueller PR
    Ann Thorac Surg; 2008 Oct; 86(4):1131-8. PubMed ID: 18805147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invited commentary.
    Low DE
    Ann Thorac Surg; 2008 Oct; 86(4):1138. PubMed ID: 18805148
    [No Abstract]   [Full Text] [Related]  

  • 7. Application of positron emission tomography imaging to personalize esophagogastric cancer care.
    Mondaca S; Janjigian YY
    Cancer; 2019 Apr; 125(8):1214-1217. PubMed ID: 30668898
    [No Abstract]   [Full Text] [Related]  

  • 8. Case records of the Massachusetts General Hospital. Case 19-2009. A 63-year-old woman with carcinoma of the gastroesophageal junction.
    Kwak EL; Hong TS; Berger DL; Forcione DG; Uppot RN; Lauwers GY
    N Engl J Med; 2009 Jun; 360(25):2656-64. PubMed ID: 19535805
    [No Abstract]   [Full Text] [Related]  

  • 9. Computed tomography in the staging of gastrointestinal carcinoma.
    Moss AA
    Radiol Clin North Am; 1982 Dec; 20(4):761-80. PubMed ID: 6758033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET and PET-CT in esophageal and gastric cancer.
    Wieder HA; Krause BJ; Herrmann K
    Methods Mol Biol; 2011; 727():59-76. PubMed ID: 21331929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, part 1.
    Schefter TE; Patel M; McCarter M; Kane M; Russ PD; Nash SR; Shah RJ; Mitchell JD
    Oncology (Williston Park); 2005 May; 19(6):775-8, 783-4, 788 passim. PubMed ID: 15971452
    [No Abstract]   [Full Text] [Related]  

  • 12. [New aspects of neoadjuvant therapy of malignant tumors of the upper gastrointestinal tract].
    Mönig SP; Berlth F; Chon SH
    Zentralbl Chir; 2014 Dec; 139(6):569-71. PubMed ID: 25674647
    [No Abstract]   [Full Text] [Related]  

  • 13. New trends for staging and therapy for localized gastroesophageal cancer: the role of PET.
    Lordick F; Ott K; Krause BJ
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii294-9. PubMed ID: 20943631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal tract malignancies and positron emission tomography: an overview.
    Esteves FP; Schuster DM; Halkar RK
    Semin Nucl Med; 2006 Apr; 36(2):169-81. PubMed ID: 16517238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoplasms of the esophagus and stomach.
    Dehdashti F; Siegel BA
    Semin Nucl Med; 2004 Jul; 34(3):198-208. PubMed ID: 15202101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of (18)flourodeoxyglucose positron emission tomography on the management of gastroesophageal junction carcinoma.
    Smith JW; Moreira J; Abood G; Aranha GV; Nagda S; Wagner RH; Shoup M
    Am J Surg; 2009 Mar; 197(3):308-12. PubMed ID: 19245906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. It is time for a proper staging system for adenocarcinoma of the gastroesophageal junction.
    Pedrazzani C; de Manzoni G; Marrelli D; Roviello F
    J Clin Oncol; 2007 Mar; 25(7):907-8; author reply 908-9. PubMed ID: 17327616
    [No Abstract]   [Full Text] [Related]  

  • 18. Staging of esophageal and gastric cancer in 2014.
    Yegin EG; Duman DG
    Minerva Med; 2014 Oct; 105(5):391-411. PubMed ID: 25000218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving role of (18)F-fluorodeoxyglucose positron emission tomography in the management of esophageal carcinoma.
    Dam HQ; Manzone TM; Sagar VV
    Surg Oncol Clin N Am; 2006 Oct; 15(4):733-49. PubMed ID: 17030270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoplasms of the upper gastrointestinal tract.
    Trenkner SW; Halvorsen RA; Thompson WM
    Radiol Clin North Am; 1994 Jan; 32(1):15-24. PubMed ID: 8284355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.